SR59230A [Ligand Id: 547] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1326499
  • β1-adrenoceptor/Beta-1 adrenergic receptor in Human [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588]
There should be some charts here, you may need to enable JavaScript!
  • β2-adrenoceptor/Beta-2 adrenergic receptor in Human [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
There should be some charts here, you may need to enable JavaScript!
  • β3-adrenoceptor/Beta-3 adrenergic receptor in Human [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945]
  • β3-adrenoceptor in Mouse [GtoPdb: 30] [UniProtKB: P25962]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
β1-adrenoceptor/Beta-1 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588]
ChEMBL Antagonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation F 7.43 pKd 37.15 nM Kd Eur J Med Chem (2023) 246: 114961-114961 [PMID:36495629]
GtoPdb - - 7.5 pKi - - - Br J Pharmacol (2005) 144: 317-22 [PMID:15655528];
J Pharmacol Exp Ther (1999) 290: 649-55 [PMID:10411574];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077]
GtoPdb - - 8.4 pKi - - - Br J Pharmacol (2005) 144: 317-22 [PMID:15655528];
J Pharmacol Exp Ther (1999) 290: 649-55 [PMID:10411574];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
ChEMBL Agonist activity at human beta1-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation F 7.32 pEC50 47.86 nM EC50 Eur J Med Chem (2023) 246: 114961-114961 [PMID:36495629]
GtoPdb - - 8.2 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
J Pharmacol Exp Ther (2005) 313: 1163-71 [PMID:15716385];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
ChEMBL Antagonist activity at human beta2-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation F 8.42 pKd 3.8 nM Kd Eur J Med Chem (2023) 246: 114961-114961 [PMID:36495629]
GtoPdb - - 9.3 pKi - - - J Pharmacol Exp Ther (1999) 290: 649-55 [PMID:10411574];
Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 151-9 [PMID:14730417];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
GtoPdb - - 9.3 pKi - - - J Pharmacol Exp Ther (1999) 290: 649-55 [PMID:10411574];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
ChEMBL Agonist activity at human beta2-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation F 8.06 pEC50 8.71 nM EC50 Eur J Med Chem (2023) 246: 114961-114961 [PMID:36495629]
GtoPdb - - 8.4 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
GtoPdb - - 8.4 pA2 - - - Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
β3-adrenoceptor/Beta-3 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945]
ChEMBL Antagonist activity at human beta3-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as inhibition of fenoterol-induced CRE-SPAP production by measuring rightward shift of the fenoterol concentration response curve measured after 5 hrs incubation F 7.16 pKd 69.18 nM Kd Eur J Med Chem (2023) 246: 114961-114961 [PMID:36495629]
GtoPdb - - 7.4 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 151-9 [PMID:14730417];
PLoS ONE (2010) 5: e15487 [PMID:21152092];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
GtoPdb - - 8.4 pKi - - - J Pharmacol Exp Ther (1999) 290: 649-55 [PMID:10411574];
Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 151-9 [PMID:14730417];
PLoS ONE (2010) 5: e15487 [PMID:21152092];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
ChEMBL Agonist activity at human beta3-adrenergic receptor expressed in CHO-K1 cells co-expressing CRE-SPAP reporter gene assessed as CRE-SPAP production measured after 5 hrs incubation F 6.72 pEC50 190.55 nM EC50 Eur J Med Chem (2023) 246: 114961-114961 [PMID:36495629]
GtoPdb - - 7.6 pEC50 - - - Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Mol Pharmacol (2005) 68: 1645-55 [PMID:16129733];
Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
GtoPdb - - 7.2 pA2 - - - Eur J Med Chem (2023) 246: 114961 [PMID:36495629]
β3-adrenoceptor in Mouse [GtoPdb: 30] [UniProtKB: P25962]
GtoPdb - - 8.3 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (2006) 373: 158-68 [PMID:16601951]

ChEMBL data shown on this page come from version 37:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]